Cherokee Global Brands Amends Credit Facility with Cerberus
Nov 13, 2017 14:01 pm UTC| Business
SHERMAN OAKS, Cali., Nov. 13, 2017 -- New financial terms provide greater financial flexibility Amendment to eliminate obligation to call equity commitments ...
Fortinet Redefines Expectations for Next-Generation Firewalls in the Enterprise
Nov 13, 2017 14:01 pm UTC| Business
SUNNYVALE, Calif., Nov. 13, 2017 -- John Maddison, senior vice president of products and solutions at Fortinet “Encrypted traffic is becoming a growing hole in enterprise defenses as organizations move to the cloud and...
Nov 13, 2017 14:01 pm UTC| Business
NORCROSS, Ga., Nov. 13, 2017 -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced that Peter G. Traber, M.D., the Company's chief executive officer...
Rocky Mountain High Brands Schedules Investor Conference Call
Nov 13, 2017 14:01 pm UTC| Business
DALLAS, Nov. 13, 2017 -- Rocky Mountain High Brands, Inc. (OTCQB:RMHB), a fully reporting consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products and a...
West Corporation Announces Leadership Changes
Nov 13, 2017 14:01 pm UTC| Business
OMAHA, Neb., Nov. 13, 2017 -- West Corporation (“West” or the “Company”) today announced three additions to its executive leadership team. Robert Wechsler will be joining the Company as President. Rob has 20 years...
eWellness Cancels Reverse Stock Split
Nov 13, 2017 14:01 pm UTC| Business
Culver City, CA,, Nov. 13, 2017 -- eWellness Healthcare Corporation,– (OTCQB: EWLL) – a provider of the state of the art PHZIO Platform for the physical therapy and telehealth markets, announced today that it has...
Alarm.com to Host Analyst and Investor Day
Nov 13, 2017 14:01 pm UTC| Business
TYSONS, Va., Nov. 13, 2017 -- Alarm.com Holdings, Inc. (Nasdaq:ALRM), the leading platform for the intelligently connected property, announced today that it will host an Analyst and Investor Day on November 15, 2017...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update